News Summary

• The US Food and Drug Administration warned Thursday that it’s seized “thousands of units” of counterfeit versions of the type 2 diabetes drug Ozempic from the US drug supply chain, and it’s urging suppliers, pharmacies and patients to use caution..
• The pen label, carton, information for patients and health care professionals, and needles that come with the injectors are also counterfeit, the FDA said..
• The FDA warns pharmacies, health care systems, wholesalers and patients to double-check their semaglutide products to make sure they are the real thing..
• Since the popularity of Ozempic and its sister medication for weight loss, Wegovy, have grown, there have been reports of people selling knockoff versions at salons and through social media..
• Novo Nordisk has sued to keep medical spas, medical clinics and weight loss clinics from selling fake versions..
• The FDA said it is working with other federal agencies and Novo Nordisk to remove additional counterfeit semaglutide injectable products..